Advanced Pancreatic Cancer Pipeline Therapeutics and Analysis, 2021 – GlobeNewswire

Las Vegas, USA, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Advanced Pancreatic Cancer Pipeline Therapeutics and Analysis, 2021

ERYtech Pharma, GlaxoSmithKline, Galera Therapeutics, Propanc and several other key companies are set to transform the Advanced Pancreatic Cancer Pipeline landscape in the coming years.

DelveInsights, Advanced Pancreatic Cancer Pipeline Insights, 2021 report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Advanced Pancreatic Cancer pipeline landscape. It comprises Advanced Pancreatic Cancer pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Advanced Pancreatic Cancer therapeutics assessment by product type, stage, route of administration, and molecule type, and further highlights the inactive Advanced Pancreatic Cancer pipeline products.

Key Advanced Pancreatic Cancer Pipeline Report Highlights

Request for free sample pages @ Advanced Pancreatic Cancer Therapeutics

Advanced Pancreatic Cancer means cancer has spread from where it started or has come back sometime after treatment (recurrence). Advanced Pancreatic Cancer Treatment is usually chemotherapy. Chemotherapy travels via the bloodstream to reach cancer cells, which are in many places throughout the body. This treatment may reduce the tumors or impede their growth and may benefit patients to live longer.

Advanced Pancreatic Cancer Pipeline Therapeutics

The lead product candidate, Eryaspase consists of L-asparaginase encapsulated inside donor-derived red blood cells, targets the cancer cells altered asparagine and glutamine metabolism. Eryaspase is in phase III clinical development for the second-line pancreatic cancer treatment and in phase II for first-line triple-negative breast cancer treatment. Leveraging its proprietary ERYCAPS platform that utilises a novel technology to encapsulate drug substances inside red blood cells, ERYtech develops a pipeline of product candidates for patients with high unmet medical needs.

For further product profiles, request @ Advanced Pancreatic Cancer Pipeline Insight Report

Scope of Advanced Pancreatic Cancer Pipeline Drug Insight

Key Questions regarding Current Advanced Pancreatic Cancer Treatment Landscape and Emerging Therapies Answered in the Pipeline Report

Table of Contents

Get customised pipeline report @ Advanced Pancreatic Cancer Pipeline Report

Related Reports

DelveInsight's Advanced Pancreatic Cancer Market Insights, Epidemiology and Market Forecast 2030 report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology.

DelveInsight's Advanced Pancreatic Cancer - Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Advanced Pancreatic Cancer in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

DelveInsight's Metastatic Castration-Resistant Prostate cancer - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology.

DelveInsights Neoantigen-based Personalized Cancer therapeutic Vaccines-Competitive Landscape and Market Forecastby 2035 report delivers an in-depth understanding of the Neoantigen-based Personalized Cancer therapeutic Vaccines.

DelveInsight's Morquio Syndrome Market Insights, Epidemiology and Market Forecast - 2030 report provides detailed insights on historical and forecasted epidemiology.

DelveInsight's Hepatic Encephalopathy - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology.

DelveInsights ICONS-Next Generation Immunotherapy- Competitive Landscape and Market Forecast2035 report delivers an in-depth understanding of the ICOS as well as the market trends of ICOS-Next Generation Immunotherapy.

DelveInsight's Buergers Disease Market Insights, Epidemiology and Market Forecast - 2030 report provides detailed insights on historical and forecasted epidemiology.

DelveInsight's Diabetes Market Insights, Epidemiology and Market Forecast - 2030 report provides thorough insights on epidemiology and market trends.

DelveInsight's Diverticulitis Market Insights, Epidemiology and Market Forecast - 2030 report provides detailed insights on historical and forecasted epidemiology.

DelveInsight's ATCL Market report 2030 delivers an in-depth understanding of the disease, historical and forecasted epidemiology, market trends in 7MM.

DelveInsight's "Goitre Market Insight Report 2030" delivers an in-depth comprehension of historical and forecasted epidemiology, market share, trends and forecast in the 7MM.

DelveInsight's Clostridium Difficile Infections Market Insights, Epidemiology and Forecast 2030 report provides a detailed overview of the disease & understanding of forecasted epidemiology.

About DelveInsightDelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.

Originally posted here:

Advanced Pancreatic Cancer Pipeline Therapeutics and Analysis, 2021 - GlobeNewswire

Related Post

Comments are closed.